Phase 4 timing: Phase 4 occurs after which event and before which?

• A. Phase 4 occurs after the NDA is submitted and before FDA approval.
• B. Phase 4 occurs after FDA approval and before market launch.
• C. Phase 4 occurs after Phase 3 and before Phase 2.
• D. Phase 4 occurs after Phase 1 and before Phase 2.

Answer: (A)

Phase 4 is post-marketing surveillance, meaning it happens after the drug has been approved by the FDA and released to the market. The usual timeline is Phase 1, 2, and 3 trials to establish safety and efficacy, followed by submitting an NDA after Phase 3. The FDA reviews the NDA and grants approval; only then is the drug marketed. Phase 4 studies monitor long-term safety, rare adverse effects, and effectiveness in broader patient populations, and they can lead to labeling changes or new indications.

Because of that, Phase 4 occurs after FDA approval and after the drug is on the market. The options describing Phase 4 as occurring before FDA approval or before market launch don’t fit this sequence.